Yasmina Kattou // Photo credit: PEAKSTOCK / SCIENCE PHOTO LIBRAR / LDA / Science Photo Library via AFP
The French company Lattice Médical, which was awarded the Trophées de l’Avenir d’Europe 1 a few months ago, is launching a clinical trial for its new technology: a resorbable breast prosthesis, therefore without residue. An alternative to silicone prostheses, the latter allows the breast to reform naturally. But what does this innovation look like and how does it work?
It is a small rigid dome the size of the breast to be reconstructed which is slipped under the skin with fatty tissue taken from the patient. The tissues will then regenerate naturally in six months to form a breast. “When we do breast reconstruction with a silicone implant, in the long term, we have a breast implant which must be changed approximately every ten years. The new device will disappear in 18 to 24 months,” explains Pierre Guerreschi , plastic surgeon, is responsible for the clinical trial at Lille University Hospital.
A prosthesis accessible within three years
Many women affected by breast cancer would like to benefit from this prosthesis. Julien Payen, co-founder of Lattice Médical, says that affected women can participate in the tests. “So that patients can check if they are eligible for the trial, they can contact the Lille University Hospital, the plastic surgery department or the gynecology department. It is then the Lille University Hospital which will come back to them to a first consultation”, he explains.
Patients should have access to this new generation prosthesis within three years.